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The zebrafish model 
Native to the freshwater pools and streams in Southern Asia, Danio rerio is a small tropical teleost 
fish belonging to the family Cyprinidae, under the class Actinopterygii (Meyer et al., 1993; 
Arunachalam et al., 2013). It gets the common name “zebrafish” from the longitudinal dark blue and 
silver-yellow stripes on either side of its compressed body, extending to the anal fin and onto the 
caudal fin rays of the tail (Grunwald and Eisen, 2002; Schilling, 2002; Engeszer et al., 2007).  
Adult female and male zebrafish are easily recognizable from their secondary sexual characteristics, 
such as body shape and pigmentation. Females show a rounder belly full of eggs, a visible oviduct 
near the anal fin and they tend to have blue and white colouring. In contrast, males are sleeker and 
have a bright yellow pigmentation, due to the testosterone (Yu et al., 2018). 
Zebrafish are easy to breed and relatively inexpensive to keep, while embryos are transparent and 
have rapid development. Moreover, zebrafish share many biological features, genes, developmental 
processes, anatomy and physiology with their human counterparts (Zhang et al., 2003). Given these 
strengths, the zebrafish has recently become a popular model organism for scientific research in 
several fields, including Biomedicine, Toxicology, Environmental Science, Biotechnology and 
Aquaculture (Lieschke & Currie, 2007).  
The pioneer works that defined zebrafish as a versatile model organism date back to the late 1960s, 
when George Streisinger first realized the potential of this small vertebrate and chose it for his genetic 
studies at University of Oregon. The publishing by Streisinger and his colleagues in the early 1980s, 
along with the evident advantages offered by zebrafish, contributed to its widespread adoption as a 
model organism for developmental biology and other fields (Lieschke & Currie, 2007; Ablain & 
Zone, 2013; Giannaccini et al., 2014). 
The identification of thousands of zebrafish mutant lines in the early 1990s (Mullins & Nüsslein-
Volhard, 1993; Driever et al., 1994) and the sequencing of the zebrafish genome, performed from 
2001 to 2013 (Howe et al., 2013) have provided a clearer understanding of critical genomic features.  
Thus, the zebrafish research community has grown exponentially over the last decades, leading to a 






Zebrafish development and life cycle 
 
Being a poikilothermic organism, incubation temperature affects developmental rate of zebrafish. In 
1995, Kimmel and his collaborators firstly described the zebrafish developmental stages based on 
morphology and timing as standard hours post fertilization (hpf) at 28.5°C (Kimmel et al., 1995). 
Today, all papers discussing on zebrafish developmental stages refer to this work. 
After fertilization, cytoplasm flows towards the animal pole to separate the blastodisc from yolk. The 
first meroblastic division starts the cleavage period at about 45 minutes post-fertilization. After this 
point, cell cycles take around 15 minutes and successive cell divisions occur synchronously. At the 
16-cell stage, central cells become separated from marginal blastomeres, which at first remain 
anchored to the yolk by cytoplasmic bridges, and subsequently collapse to form the multinucleate 
yolk syncytial layer (Kimmel et al., 1995; Meyers, 2018). From the 128-cell stage, the developing 
embryo is called blastula, and consists of a mass of cells at the animal pole. The tenth cell cycle marks 
the Mid-Blastula Transition, when cell divisions are longer and asynchronous compared to previous 
stages, and embryonic development comes under the control of the zygotic genome. The Mid-
Blastula Transition also marks the start of cellular motility, and thus the beginning of morphogenetic 
movements leading to the onset of epiboly and the spreading of blastoderm across the yolk (Webb & 
Miller, 2006). From this stage onwards, the “epiboly percentage” defines the advancement of the 
process that leads the yolk to be surrounded completely by the blastoderm. In agreement with this 
nomenclature, the blastula period ends when the blastoderm margin covers the 30% of the entire 
distance between animal and vegetal poles, which is called the “30% epiboly stage”. 
Gastrulation involves epiboly continuation and simultaneous morphogenetic cell movements that 
generate the primary germ layers and the embryonic axis. In particular, at the 50% epiboly-stage 
(around 6hpf), cell involution induces a folding of blastoderm on itself. Due to this event, two germ 
layers, epiblast and hypoblast, can be distinguished within the so-called germ ring. At the end of 
gastrulation, the epiblast corresponds to the ectoderm, which will give rise to epidermis, central 
nervous system, neural crest and sensory placodes, while the mesoderm and endoderm will originate 
from the hypoblast. Subsequently, convergence of the cells at one side of the germ ring produces the 
so-called “shield”, which marks the dorsal side of the embryo, thus allowing orientation of the dorsal-
ventral axis (Kimmel et al., 1995; Webb & Miller, 2006; Meyers, 2018).  
Epiboly arrests temporarily during these phenomena and it starts again from shield stage, being 
completed at the “Bud stage” (10hpf), when the tail bud has formed and gives the name to this stage. 




organizing centre for the development of the posterior trunk. The head, instead, develops from a thick 
region near the animal pole. At the bud stage, gastrulation is considered to be over and the embryo 
starts to exhibit signs of segmentation. During this phase, ectoderm, mesoderm and endoderm 
undergo modifications and give rise to the primary rudimentary organs. Somites appear in sequence, 
starting from the head region towards the tail. In the later stages of segmentation, morphogenesis 
produces a significant increase in length of the embryo, involving the detachment of the tail from the 
body and the extension of the posterior region of the yolk (Kimmel et al., 1995; Webb & Miller, 
2006). 
The Pharyngula period starts at 24hpf and represents the phylotypic stage, that is the stage at which 
the embryo shows the basic vertebrate body plan (Kimmel et al., 1995; Collazo, 2000). The term 
“pharyngula” refers to the pharyngeal arches that become gradually distinguishable during this phase.  
The embryo continues its lengthening and, consequently, the head straightens out while the head-
trunk angle increases. This developmental stage also involves pigment cell differentiation and the 
formation of the circulatory system (Kimmel et al., 1995). 
The hatching from the chorion, between 48 and 72hpf, represents the transition from the embryonic 
to the larval stage. Most organs of the early larva are nearly complete, except for those in the 
gastrointestinal tract, which develop in the time range between 72 and 96hpf (van Wijk et al., 2016). 
Overall, larvae undergo further body growth and specification, including swim bladder inflation, 
protrusion of the mouth and movements of the jaws and fins, which allow active swimming and, 
shortly thereafter, independent feeding from about 120hpf (Meyers, 2018). 
Zebrafish take about four weeks to complete their larval period and reach about eleven millimetres 
of length, conventionally recognized as the marker of having reached the juvenile stage. During this 
time span, growth progression and terminal differentiation processes are particularly challenging to 
standardize, since they depend on factors such as temperature, density of population and organism-
specific differences (Meyers, 2018).  
Zebrafish reach sexual maturity at around three or four months of age. From this moment, zebrafish 
are considered adults and they usually do not exceed four centimetres in length (Reed & Jennings, 
2011; Cassar et al., 2020).  
It has been reported that, in the wild, zebrafish life expectancy is about two years, but it can reach up 





Zebrafish as model organism for toxicological analysis 
The aim of toxicology is to determine the safety and effectiveness of possible new drug candidates 
(Nass et al., 2018). In this perspective, evaluations on biological systems, in vitro and/or in vivo, are 
needed to reveal the species-, organ- and dose-specific effects of the substances under investigation 
(Parasuraman, 2011; Cornet et al., 2018). Cell or tissue cultures allow cheap, rapid and high-
throughput analysis, but they lack of physiological context, resulting in low predictive power of 
toxicity. On the other hand, experimentation on model organisms evolutionarily close to humans is 
long and expensive, and heavily restricted by country- and agency-specific ethical standards (Ali et 
al., 2011; Truong et al., 2011; He et al., 2014). The use of zebrafish as model organism for 
toxicological analysis overcomes these limitations by combining the power of whole-animal 
investigations with small resources requirement comparable to those of cell culturing (Truong et al., 
2014; Nishimura et al., 2015; Cornet et al., 2018).  
The most advantageous aspects of this animal model arise from the early developmental stages. 
Fertilization is external and embryos maintain their transparency until the larval stage, thus 
facilitating detailed evaluation of physiological structures and organ systems. Moreover, embryo 
development is very rapid, thereby sensibly reducing the experimentation time (Glass & Dahm, 2004; 
Veldman & Lin, 2008). The chorion is permeable to a range of small molecules, allowing 
administration of the compounds of interest directly into the culturing medium. Furthermore, owing 
to their small size, zebrafish embryos can be individually placed in multi-well plates, thereby limiting 
the amount of materials required per experiment (He et al., 2014; Truong et al., 2014). 
Other aspects of zebrafish biology further avail their usefulness as model organism for screening and 
testing. Notably, zebrafish have high fecundity and fast life cycle. Once they reach sexual maturity, 
females are able to spawn several hundred eggs weekly. Such large offspring sizes provide an ideal 
platform for high-throughput assays with high statistical power (Veldman & Lin, 2008; Arunachalam 
et al., 2013). Furthermore, captive zebrafish live can breed all year round instead of seasonally, 
thereby avoiding time limitations on research (Ali et al., 2011; Meyers, 2018). 
Besides these biological aspects, zebrafish maintenance is easier and cheaper than mammalian 
models, thus allowing low cost experimentation. 
Additional features support the use of zebrafish as model organism for toxicological assessments. 
Comparison of the zebrafish to human protein-coding genes revealed not only that 70% of human 
genes possess at least one zebrafish orthologous, but also that 82% of human morbid genes have a 




shared function, because of the whole-genome duplication event occurring in the teleost lineage 
(Howe et al., 2013). Therefore, zebrafish may have two copies of each human orthologue and this 
enhances analyses of gene regulation (Phillips & Westerfield, 2014).  
Toxicity tests in drug development involve the study of absorption, distribution, metabolism and 
excretion phenomena, collectively referred to as ADME. Since zebrafish embryos and larvae share 
several physiological, morphological similarities with mammals, they can conveniently substitute 
mammal models for ADME studies in pharmacology (Pellegatti, 2012; Diekmann & Hill, 2013; 
Cornet et al., 2018). Moreover, the use of zebrafish as model organism brings direct Replacement, 
Reduction and Refinement (3Rs) benefits required by the European Directive 2010/63 on the ethical 
use of animals for scientific purposes. These principles apply to all non-human vertebrates and 
independently feeding larval forms. Hence, another aspect promoting the use of zebrafish in research 
is that larvae up to 120hpf do not fall into regulatory frameworks dealing with animal 
experimentation, because zebrafish start seeking prey and feed independently after 120hpf (Fleming 
et al., 2007).  
The reliability of zebrafish models lies not only in the zebrafish homology to mammalian morphology 
and biology, but also to behaviour. In particular, both larvae and adult zebrafish display a wide range 
of complex behaviour patterns, including social, anxiety, learning, memory and defensiveness, 
closely parallel to mammalian, thus suggesting the evolutionarily conserved nature of many 
behaviours across species (Kalueff et al., 2014; Stewart et al., 2014). Indeed, despite neuroanatomical 
differences between mammals and teleosts, homologous functions exist in several key zebrafish brain 
areas (Randlett et al., 2015; Perathoner et al., 2016; Lucini et al., 2018). In addition, locomotion in 
zebrafish results from a complex network of evolutionarily conserved pathways and neurotransmitter 
systems (Grillner et al., 2005; Horzmann et al., 2016). Data collected from larval locomotion are 
successfully considered for identifying potential central nervous system beneficial and side effects of 
new drugs, as well as for detecting therapeutic and target specificity of compounds (Kokel et al., 
2010; Bruni et al., 2014; Khan et al., 2017; Fontana et al., 2018).  
Taken together, the aforementioned factors highlight the versatility and appropriateness of zebrafish 
as experimental model system for comprehensive large-scale high-throughput chemical screenings, 
allowing at the same time the minimization of the use of mammalian models without losing reliability 






Finding novel therapies is the main goal of toxicity testing for drug development processes. In this 
context, cell culture-derived conditioned media have been proposed as a promising pharmaceutical 
candidate for regenerative medicine (Kim and Choi, 2013; Vizoso et al., 2017). Conditioned media 
are formed during culturing, when cells secrete into the extracellular space many factors, collectively 
referred to as the secretome, including soluble proteins (e.g. growth factors, chemokines, cytokines), 
free nucleic acids (e.g. microRNAs), lipids, and different extracellular vesicles. Although a 
conditioned medium can be harvested from various cell types, the same cells can yield different 
secretomes depending on the overall cell number, culture duration and conditions (e.g. 
normoxia/hypoxia, monolayer/spheroid cultures) (Pawitan, 2014; Vizoso et al., 2017).  
For almost two decades, mesenchymal stem cells-based therapies have been successfully employed 
in regenerative medicine (Vizoso et al., 2017). However, the work of Gnecchi et al. in 2005 showed 
that the paracrine factors released by the cells are responsible for the observed beneficial effects 
(Gnecchi et al., 2005). Thereafter, several studies on the application of cell-derived secretome in 
various degenerative diseases revealed the improvement of the pathological conditions after the 
treatments. It has been demonstrated that mesenchymal stem cell-derived conditioned medium is 
sufficient to significantly improve multiple biomarkers of pathophysiology, and, in general, to be as 
effective as transplantation of the corresponding mesenchymal stem cells in several animal models, 
especially rodents (Vizoso et al., 2017). 
Due to their composition, conditioned media may have anti-apoptotic, anti-microbial and anti-
tumoral effects. Furthermore, they have a beneficial role in wound healing and tissue repair, having 
a correlation with the angiogenetic and neurotrophic effects observed (Mishra & Banerjee, 2012; Beer 
et al., 2017; Vizoso et al., 2017; Sohn et al., 2018). Given the aforementioned evidence, the use of 
conditioned medium in regenerative medicine is very appealing. In addition, it may offer considerable 
potential advantages over living cells-based therapies, in terms of manufacturing, storage and 
handling. 
Conditioned media can be easily stored, freeze-dried, packaged and transported without loss of 
product potency. Furthermore, mass-production of ready-to-use conditioned media is possible 
through tailor-made cell lines under controlled conditions to obtain the convenient composition for 
therapeutic applications. In this way, it is possible to reduce the time and cost of expansion and 




Noteworthy, the adoption of cell-free therapies rather than cell engrafts avoids rejection by the target 
organism and reduces other related risks, such as immune compatibility, tumorigenicity and the 
transmission of infections (Pawitan, 2014).  
Given all these strengths, cell-derived conditioned media display promising prospects as 
pharmaceuticals for regenerative medicine. Therefore, conditioned media must be preventively 
evaluated for safety, efficacy and dosage in a manner analogous to pharmaceutical agents (Kim & 
Choi, 2013; Vizoso et al., 2017). From this perspective, in vivo toxicity assays for these products are 
essential and zebrafish embryo is the best model organism to use for this purpose. However, literature 
on zebrafish conditioned media assays is still very limited, mostly relating to studies on adult 



























The fulcrum of the work described in this thesis is the use of zebrafish for translational research. 
Since the zebrafish laboratory recently established at the University of Palermo has been authorized 
slightly before the start of this PhD project, the preliminary purpose was to improve the maintenance 
of the fish facility by applying and optimizing protocols for regular housing, feeding, breeding adult 
fish and handling embryos. In doing so, we ensured the optimal life conditions for zebrafish to obtain 
viable and sufficient offspring for performing the downstream experiments. 
Then, to combine at best both the aims of the PhD course in Technologies and Sciences of Human 
Health, we organized our work in two main sections: one mostly technological and one purely 
scientific. In particular, we first devised a multi-parametric assay platform for the in vivo toxicological 
analysis of potential therapeutic compounds and new drug candidates. This assay allows rapid and 
simultaneous analysis of morphological, apoptotic, behavioural and molecular changes inflicted by 
multiple compound at different concentrations during zebrafish embryogenesis. 
Once the robustness of this pipeline was successfully validated using distinct chemicals known to 
induce developmental aberrations in zebrafish, we challenged it using complex biological samples. 
Intriguingly, we show that exposure of zebrafish embryos to conditioned media derived from 
Wharton's jelly mesenchymal stem cells confers protective effects against apoptosis and oxidative 
stress. 
Altogether, these findings not only provide a novel implementation of current in vivo toxicological 










MATERIALS AND METHODS 
Facility management and husbandry conditions 
Wild type AB strain zebrafish (Danio rerio) were housed in the fish facility of the Advanced 
Technologies Network Center (Aut. n. 06/2017-UT 30/03/2017) of the University of Palermo. All 
the experiments described in this thesis were performed exclusively on embryos and larvae within 5 
days post fertilization (dpf), thus not subject to animal experimentation rules according to European 
(2010/63/UE) and Italian (D. lgs. 26/2014) directives. 
Fish were housed in tanks held in automatic circulating systems Tecniplast – ZebTec ActiveBlue 
Stand Alone that automatically controls the following parameters: 
 Temperature: 28.5°C 
 Conductivity: 300 ± 50 μS 
 pH: 6.5-7.5  
The system was periodically provided with a 0.6% Sodium Bicarbonate (Sigma Aldrich) solution and 
a 0.6% Instant Ocean® (Aquarium Systems) solution to make adjustments and ensure the right values 
of pH and conductivity, respectively. Lighting conditions were kept at a fixed 14-10 hours light-dark 
cycle. 
Fish were kept at a maximum density of 5 fishes/L and fed twice a day with live and newly hatched 
brine shrimps (Artemia salina) and with dry flakes (Tetra® TetraMin® Tropical Flakes). Artemia 
salina cysts were placed, at a density of 5g of cysts per liter, in specific aerated brine shrimp hatcher 
(Hatch-Rite III, Florida Aqua Farms) filled with 3% NaCl osmotic water at 25°C. After 48 hours, the 
aeration was removed and the hatched nauplii are collected with a brine shrimp sieve. The nauplii 
were rinsed twice with system water and then fed to the fish with a plastic Pasteur pipette (about 2ml 
for 5 fish). 
Male and female adult fish were preferably housed in separated tanks and set up in pairwise crosses 
(ratio 1:1) in the afternoon before embryos were required. Male and female were separated through a 
divider in specific 1 liter-breeding tanks filled with static water. The divider was removed the next 
morning, shortly after the onset of light, allowing fishes to spawn. The fish were left to mate 




Experimental pipeline for toxicological analysis on developing zebrafish 
Embryo handling and chemical exposure 
The assay was based on the OECD guidelines on Fish Embryo Toxicity (OECD, 2013a; OECD, 
2013b). Newly laid embryos were obtained by natural and spontaneous fertilization by coupling 
males and females in appropriate conditions. Embryos were collected using a strainer, rinsed in E3 
medium (Westerfield, 2007; https://zfin.org/zf_info/zfbook/cont.html) added with Methylene Blue 
(Sigma-Aldrich, CAS no.122965-43-9) and transferred in Petri dishes, labelled with birth date and 
parental couple tank number. Unfertilized eggs and debris were removed and embryos were incubated 
in Petri dishes at 28.5°C until staged for following steps. 
At 4hpf, synchronous and healthy embryos were selected and gently transferred (1 embryo/well) 
using a sterile plastic Pasteur pipette into sterile 96 well-plates (Costar 3599, Corning Inc.). 
Embryos were never allowed to dry out and were incubated in E3 medium at all times until chemical 
exposure at 6hpf. The developmental stage was determined according to the description of zebrafish 
development of Kimmel et al. (Kimmel et al., 1995). 
The following compounds were used for protocol set up. The concentrations used are sub-lethal in 
light of the data of previous studies: 
 Cadmium chloride (CdCl2) (Carlo Erba, CAS no. 35658-65-2): 9μM – 25μM – 50μM 
(Monaco et al., 2017; Capriello et al., 2019) 
 Dimethylsulfoxide (Sigma Aldrich, CAS no. 67-68-5): 1% – 1.5% – 2% (Chen et al., 2011) 
 Ethanol (Sigma-Aldrich, CAS no. 111-76-2): 1% – 2% (Chen et al., 2011 Ramlan et al., 
2017) 
 Tricaine (MS-222 Sigma-Aldrich, CAS no: 886-86-2): 50mg/L – 100mg/L – 150mg/L 
(Félix et al., 2018) 
Chemicals of interest were diluted in E3 medium to reach the desired concentrations. E3 medium was 
removed from each well containing an embryo and replaced with 200μl of either freshly prepared 
solution. For each concentration, at least 12 embryos were used, while 12 other embryos were for 







Microinjection needles were prepared by pulling capillary glass tubes (80 millimeters in length, 1/0.8 
mm OD/ID millimetre. Cavù s.r.l.) using Narishige Electrode Micropuller (Heater = 8; Magnet = 7.5; 
Main Magnet = 9.5). The needle was backloaded with 2μl of 0.05 % Phenol Red (Sigma-Aldrich) in 
E3 medium and then inserted into the needle holder on the Narishige MN-4 Micromanipulator in a 
proper position to allow for a wide range of movement and adjustment. The tip of the injection needle 
was opened under the Leica M-205FA Stereomicroscope using Dumont #5 fine forceps to obtain a 
tip opening of about 20μm. The size of the droplets injected by the needle was calibrated before 
starting each microinjection session. To do this, the pressure and the time of injection were modulated 
on the Eppendorf FemtoJet 4i Microinjector by trying several injections in a droplet of mineral oil on 
a Petri dish. Then, zebrafish larvae were anaesthetized with 0.05% Tricaine (MS-222 Sigma-Aldrich, 
CAS no: 886-86-2) in E3 medium and positioned on a handcrafted larvae holder (Fig. 1), using gel-
loading tips to gently shift them around and arrange them as appropriate. Larvae holder was prepared 
by melting 2% agarose in E3 medium and pouring it in 5 centimetres diameter-Petri dishes embedding 











Microscopic observation  
Live imaging was performed on individual embryos under the Multidimensional Fluorescence 
Stereomicroscope Leica M205 FA with Leica DFC 550 camera using Leica LAS X Software. Treated 
embryos and larvae were assessed daily, up to 120hpf, with regard to survival and morphological 
modifications compared to untreated controls. The larvae were anesthetized with 0.05% Tricaine in 
E3 medium to prevent movement during the live imaging practice. For a careful examination, the 
chorion was mechanically removed. 
Apoptotic assay 
72hpf-larvae were incubated in 2mg/ml Acridine Orange hemi (zinc chloride) salt (Sigma-Aldrich) 
in E3 medium for 20 minutes. Then, larvae were washed three times in fresh-prepared E3 medium 
before they were anaesthetized with 0.05% Tricaine (MS-222 Sigma-Aldrich). Stained larvae were 
protected from light at all times by covering the plate with aluminium foil. Visualization and 
photographing of apoptotic spots were conducted in a dark room under Multidimensional 
Fluorescence Stereomicroscope Leica Microsystems M205 FA.  
Behavioural analysis 
Alive 120hpf-larvae were selected and transferred in a 96 well-plate with one larva per well and 200μl 
of fresh E3 medium. The plate containing the larvae was positioned inside the ZebraBox observation 
chamber (ViewPoint Behavior Technologies) equipped with infrared camera. After 10 minutes of 
acclimation into the chamber, the movement of each zebrafish larva was recorded for 15 minutes 
without any disturbances. The parameters were set up as follows:  
 Colour: black 
 Detection threshold: 15 
 Movement threshold: Inact/Small = 2 mm/sec. Small/Large = 4 mm/sec  
 Time bin: 60 sec 
 Light: 50% 
The video output from the camera was analysed with the appropriate movement tracking software 
ViewPoint® ZebraLab Tracking Mode (ViewPoint® Behavior Technologies - version 3.22.3.89). 
The raw data were processed with ViewPoint® FastData Manager (version 2.4.0.2510) and the charts 




Conditioned medium (CM) exposure  
CM derived from WJ-MSC cultures were provided by our collaborators from “Azienda Ospedaliera 
Ospedali Riuniti Villa Sofia-Cervello” of Palermo. The cells were incubated with Dulbecco’s 
Modified Eagle Medium (DMEM) (HiMedia Cell Culture AT068) and cell-free medium (mentioned 
below as CM) was harvested after 48 hours of conditioning. Then, it was centrifuged to remove 
cellular debris and the supernatant was concentrated using High-Performance Liquid 
Chromatography (Lo Iacono et al., 2018).  
The CM stock solution had a concentration of 1500μg/mL (referred to as 40X), measured by Bradford 
protein assay. Starting from 6hpf, zebrafish embryos were exposed to increasing concentrations of 
CM diluted in E3 medium (1X – 2X – 4X).   
Control groups included embryos from the same batches exposed to equivalent volumes of DMEM 
and freshly prepared Saline Solution (having the same inorganic composition as DMEM: 0.265g/L 
CaCl2 · H2O, 0.1 mg/L Fe(NO)3 · 9 H2O, 1.98 g/L MgSO4 ·7 H2O, 0.4 g/L KCl, 6.4 g/L NaCl)  per 
concentration (1X – 2X – 4X). In parallel, a group of embryos reared in E3 medium was the negative 
control 
Before exposure, a hole was made on zebrafish embryo chorions, whereby ensuring that all the factors 
contained in the medium could reach the embryo regardless of their size. Zebrafish embryos were 
exposed to the treatments starting from 6hpf and their development was examined according to the 
experimental protocol described in this text. 
Primer design 
Genes of interest were selected based on literature. Information about their gene expression profile 
were retrieved from ZFIN (https://zfin.org/action/expression/search). Then, NCBI 
(http://www.ncbi.nlm.nih.gov/Genbank) and Ensembl (http://www.ensembl.org/Danio_rerio) 
searches in public sequence databases were performed to identify exons and promoter sequences for 
each selected gene. Primers were designed using the Oligo Explorer Software (version 1.1.2) and 
further validated on the Oligo Analyzer software (version 1.0.3) to have the following parameters: 
 Primer length: 18-22 mer  
 Melting temperature: 62°C 
 PCR product length: about 150 bp 




The sequences of each primer were finally checked on the zebrafish genomic reference sequences 
using Primer Blast (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to exclude non-specific 
amplification. The genes considered and the respective primer pair sequences are listed in Appendix 
A and Appendix B. 
Total RNA extraction and reverse-transcription  
Total RNA was isolated from 50 30hpf-embryos according to the protocol Purification of Total RNA 
from Animal Cells using Spin Technology of the RNeasy Mini Kit Qiagen. Before starting, embryos 
were manually dechorionated and deyolked with Deyolking Buffer. In our hands, about 20μg of total 
RNA was isolated with this procedure. RNA samples were quantified spectrophotometrically at 260 
nm, and the RNA quality was checked by 1.5% agarose gel electrophoresis.  
For the synthesis of cDNA, reverse-transcription reactions were carried out following the indications 
of the TaqMan Reverse Transcription Reagents kit (Applied Biosystems). For each sample, the cDNA 
was synthesized starting from 2.5µg of total RNA in reactions of 50μl containing 2.5μM random 
hexamers. The thermal profile was set up as recommended by TaqMan Reverse Transcription 
Reagents kit (Applied Biosystems): 
25°C     10’ 
37°C     60’         
95°C     5’ 
Chromatin ImmunoPrecipitation (ChIP) assay 
ChIP assay was performed by adapting the protocol from Lindeman (Lindeman et al. 2009). Zebrafish 
embryos at 30hpf were manually dechorionated, transferred in a 1.5 ml tube containing 300μl of 
deyolking buffer (55 mM NaCl, 1.8 mM KCl, 1.25 NaHCO3) (Link et al., 2006), and incubated for 
15 minutes. For each experiment, 100 embryos of each group were used. The embryos were gently 
pipetted with a narrow tip every 5 minutes to ease yolk dissolution. After centrifugation for 4 minutes 
at 1100 rpm to remove yolk residuals, the embryos were incubated in 300μl of trypsin solution 
(Covassin et al., 2006) at 28°C for 20 minutes, during which they were grinded by pipetting every 10 
minutes. At the same time, digestion trend was monitored by checking 2μl of solution under Leica 
DMi8 Inverted Microscope. Trypsin was blocked by adding 1mM CaCl2 and 10% fetal bovine serum. 
After centrifugation and supernatant removal, cells were rinsed twice in ice cold PBS 1X. Dry cells 




To quench formaldehyde, 0.125 M glycine was added and the cells were incubated for 5 minutes. 
After supernatant discard, the cells were resuspended in a solution of ice cold PBS 1X with 1:100 
PMSF and 1:100 Protease Inhibitor Mix (Sigma-Aldrich). Cell pellet was washed three times with 
this solution and two times with ice cold PBS 1X. 
Cell pellets were resuspended in 150μl of ice-cold Lysis Buffer (50mM Tris HCl pH 8, 10mM EDTA, 
1% SDS, 1:100 PMSF, 1:100 Protease Inhibitor Mix). Sonication was carried out in a high-power 
ultrasonic bath (Sonorex Digitec DT 103 H, Bandelin) at variable cycle numbers between 15 and 105 
(1 cycle = 30s ON/ 30s OFF) to reach the optimal average fragment size of 250bp, as determined by 
2% agarose gel electrophoresis. After sonication, the chromatin was recovered in clean tubes by 
centrifugation.  
In parallel, antibody-bead complexes were prepared. Protein A-sepharose magnetic beads (Protein A 
Mag SepharoseTM Xtra- GE Healthcare) were washed twice with 2.5 V of RIPA buffer (10mM Tris 
HCl pH 7.5, 140mM NaCl, 1mM EDTA, 0.5mM EGTA, 1% Triton X-100, 0.1% SDS, 0.1% Na-
deoxycholate). 10μl of magnetic beads slurry per each ChIP reaction were loaded in different tubes 
and incubated with 2.4μg of titrated amount of antibody overnight at 40 rpm at 4°C. Aliquots of slurry 
were incubated in the absence of antibody, as negative control. 
Afterwards, 1μg of sonicated chromatin was added for each ChIP reaction and negative control, and 
incubated for 2 hours at 40 rpm at 4°C. In parallel, an equivalent amount of cross-linked chromatin 
(Input) was withdrawn and processed as the immunoprecipitated chromatin. 
The immune-complexes were adsorbed to protein A-sepharose beads, which were sequentially 
washed twice with ice-cold RIPA and once with TE Buffer (10mM Tris HCl pH 8, 10mM EDTA). 
The immune-complexes were eluted with ChIP Elution Buffer (20mM Tris HCl pH 7.5, 5mM EDTA, 
50mM NaCl, 1% SDS, 50μg/mL Proteinase K) and incubated at 1300 rpm at 68°C for 2 hours to 
reverse the cross-linking.  
DNA from chromatin samples was extracted with phenol-chloroform and precipitated with absolute 
ethanol, sodium acetate 0.3 M and glycogen overnight at -80°C. Finally, DNA was dissolved in 50μl 
of MilliQ water. DNA samples were then quantified by readings in a Qubit Fluorometer (Invitrogen) 







Polymerase Chain Reaction 
Expression level of the genes of interest, as well as the enrichment of histone regulatory sequences 
in genomic DNA purified from the precipitated chromatin fractions, were examined by semi-
quantitative PCR, whose conditions were as follows: 
94°C     10’’  
58°C     30’’       
72°C     30’’   
72°C     2’ 
Amplification primer pairs for each target are listed in Appendix A for cDNA analysis and Appendix 
B for ChIP. Quantification of PCR products was performed on 2% agarose gel electrophoresis using 


















Set up of the facility management and husbandry conditions 
Current zebrafish husbandry conditions derives from knowledge of zebrafish natural habitat along 
with recorded experiences of maintaining in laboratory conditions (Harper & Lawrence, 2011; Reed 
& Jennings, 2011). Welfare and successful breeding are the main aspects to consider when handling 
zebrafish for scientific research. Therefore, standards and conventional approaches for zebrafish 
caring and management have been established over time from the perspective of breeding this species 
for scientific purposes (Garcia et al., 2016; Lawrence et al., 2016; Tsang et al., 2017).   
Since the zebrafish laboratory has been very recently established at the University of Palermo, we 
first optimized the facility management. In particular, we standardized all the daily operations and 
procedures according to the most recent guidelines and current law for animal welfare in scientific 
research (D. Lgs 26/2014, Dir. 2010/63/EU), in order to maintain healthy and successfully breeding 
adults (Westerfield, 2007; Reed & Jennings, 2011; Avdesh et al., 2012; Guillen et al., 2012; Geisler 
et al., 2016). 
Zebrafish are relatively tough animals, which easily tolerate a wide range of environmental 
parameters in the wild. However, in captivity zebrafish are kept under conditions that mimic the 
monsoon season, when breeding naturally occurs (Reed & Jennings, 2011). In our facility zebrafish 
are housed in tanks equipped by systems that continuously filter, aerate and disinfect water, 
guaranteeing automatic monitoring of the optimal water parameters chosen.  
The biological clock of the zebrafish is modulated by the photoperiod. In the wild, zebrafish 
experience around 10-12 hours of darkness per day. In the laboratory, setting a proper photoperiod 
replicating the circadian light cycle has a significant influence on the mating behaviour, whereas fish 
spawn early in the morning. Along this line, we set up an automatic photoperiod of 14 hours of light 
(from 9 a.m. to 11 p.m.) and 10 hours of darkness per day, as widely recommended (Westerfield, 
2007; Reed & Jennings, 2011; Tsang et al., 2017).  
The next critical step was to keep optimal temperature. Although zebrafish can survive temperatures 
from 6°C to 38°C in their natural habitat (Reed & Jennings, 2011), it is well-known that they grow 
and breed satisfactorily at a water temperature of 28.5°C (Kimmel et al., 1995; Westerfield, 2007; 
Tsang et al., 2017). For this reason, in our facility the water temperature is maintained at this value, 
while room temperature is set up about 2°C lower to guarantee a more comfortable working 




A fundamental parameter to consider for preserving zebrafish health is water salinity. In nature, 
zebrafish adapt to a variety of salinity conditions, ranging between 10 and 1500μS (Avdesh et al., 
2012). Facilities worldwide set up salinity level on their own within this range, depending on practical 
issues. In our facility, we tested two ranges of salinity: 600μS - 400μS, with optimum at 500μS; and 
400μS-200μS, with optimum at 300μS. Setting up the first salinity range leads to huge salt 
accumulation and, consequently, the risk of corrosion essential mechanical parts of the system. By 
contrast, we observed that the lower salinity range minimizes salt accumulation. Moreover, we 
verified that setting salinity around 300μS does not affect fish viability. Indeed, this condition 
replicates the dilution of water occurring in nature during breeding season, characterized by heavy 
rain (Reed & Jennings, 2011). This evidence has lead us to set the salinity around 300μS. The system 
automatically controls the salinity value and makes adjustment as needed by adding a solution of a 
commercial salt mixture specific for aquaculture.  
The pH is essential to maintain a good water environment. In nature, zebrafish live in water with a 
pH ranging from 5.9 to 8.1 (Reeds & Jennings, 2011). The pH of housing water in aquatic systems 
may have significant effects on zebrafish health. First of all, a pH level at or close to neutral allows 
the survival of beneficial nitrifying bacteria living in the biological filters of the systems. These 
beneficial bacteria metabolize the nitrogenous waste excreted by fish, as they oxidize ammonia to 
nitrite and subsequently to the much less toxic nitrate. This process acidifies water, thus reducing the 
risk of proliferation of other microbes, which can be harmful to fish and cause infections (Geisler et 
al., 2016; Tsang et al, 2017). Our system is provided with a sodium bicarbonate solution, which is 
introduced as needed into the circulating water to maintain the pH between 7 and 8.  
Water quality depends also on population density at which fish are kept inside the tanks. Zebrafish 
are shoaling fish that prefer to live in group and have small sizes, as their body length is only about 
four centimetres. For these reasons, it is possible to house efficiently a large number of individuals in 
small spaces. However, over-crowded population density is detrimental for zebrafish welfare. 
(Westerfield, 2007; Tsang et al., 2017; Alestrӧm et al., 2019). Indeed, the amount of ammonia 
excreted by fish may become too much to be neutralized by the metabolic activity of nitrifying 
bacteria, thus making zebrafish prone to infections. On the other hand, keeping fish alone may 
provoke stress and suffering. In our facility, we housed zebrafish in small groups, at a maximum 
density of 5 fishes/L, as widely recommended (Guillen, 2012).  
We generally prefer to separate fish in tanks by gender. This avoided casual spawning, aggressive 




mating. However, we allow fish to breed every week, safeguarding their welfare and their natural 
behaviour. 
Successful breeding is strictly related to an equilibrate diet (Watts et al., 2016). Zebrafish are 
omnivorous: in the wild, their diet consists of zooplankton, fitoplankton, algae, spores and 
invertebrate eggs (Spence et al., 2007). Several commercial dry aquarium flakes are available to 
provide the proper nutritional intake to fish. We made a careful selection to choose the best flakes in 
terms of value for money. We also supplement dry food with live Artemia salina nauplii. Nauplii are 
fed to fish at 24 hours after hatching, because at this stage they have a good content of proteins, 
essential fatty acids and vitamins (Westerfield, 2007). It is widely accepted that a combination of dry 
and live feeds improves survival, growth and reproductive performance (Varga et al., 2016). 
Moreover, the swimming behaviour of nauplii stimulates fish natural hunting instinct, thus providing 
an important environmental enrichment (Hoo et al., 2016; Wafer et al., 2016). 
Mating is the crucial aspect to consider in zebrafish husbandry for scientific purposes. Indeed, 
obtaining enough offspring is the first challenge for successful experiments. We improved our mating 
protocol by applying suggestions from papers (Westerfield, 2007; Engezer et al., 2007; Nasiadka & 
Clark, 2012; Hoo et al., 2016) and courses. In this way, we witnessed an increase of successful mating 
from 40% to 80% in one year.  
In nature, zebrafish mate in slow-flowing and shallow waters. For this reason, mating couples are 
placed in commercial special designed flat and shallow plastic tanks (Fig. 2). The mesh at the bottom 




Figure 2. Female (left side) and male (right side) adult zebrafish in mating tank. Red arrow indicates the divider, while 





Zebrafish spawn early in the morning, immediately after the onset of the light. Therefore, the evening 
before embryos are needed, breeding fish were set up, preferably away from meals to obtain clean 
egg clutches without excrements. Since the holding tanks are blue, we usually place the transparent 
breeding tanks on blue supports, so that the fish feel at ease and they are involved to spawn. We 
observed that this trick has often worked. When synchronous embryos are required, males and 
females are separated inside the tanks by a divider, which is removed in the morning to allow sexual 
courtship and spawning at a specific time. Otherwise, no divider is inserted and fish are free to spawn 
at any time.  
 
Set up of an experimental pipeline for toxicological analysis on developing zebrafish 
Once basic conditions for zebrafish husbandry and breeding have been set up, we devised a multi-
parametric embryo-larval experimental workflow to evaluate the developmental toxicity of new 
potential therapeutic compounds. The procedure involves the following steps: 
 
1. Exposure of embryos to specific substances  
       1a. Microinjection of specific substances 
2. Microscopic observation of developing embryos 
3. Apoptotic assay on 72hpf embryos 
4. Behavioural analysis of swimming larvae 
5. Molecular analysis: gene expression and epigenetic analysis. 
1. Exposure of embryos to specific substances  
 
Embryo treatments were conducted in 96-well plates at a density of 1 embryo per well. We started 
the chemical exposure from 6hpf, the so-called Shield stage, when the maternal-to-zygotic transition 
of gene expression is almost complete (Stehr et al, 2006; McCollum et al., 2011). To guarantee 
statistical significance, we used groups of 12 embryos per each treatment condition and untreated 
controls and each experiment was repeated with different batches of embryos. Synchronous sibling 
embryos were used in each experiment to avoid any bias in the results due to different developmental 




known for their potential toxic effects on developing zebrafish, as detailed in the Materials and 
Methods section. 
1a.   Microinjection of specific substances 
 
We have decided to further refine our pipeline by including microinjection, a widely used technique 
in experimental biology and toxicological analysis (Fig. 3), to deliver specific substances into 
selected areas of developing zebrafish. Unlike the classical Fish Embryo Toxicity Test (OECD, 
2013a; OECD, 2013b), microinjection allows direct administration of both polar and non-polar 
substances, low and high molecular size compounds or even cells, overcoming natural barriers such 




Figure 3. Preparing the microinjection apparatus under the stereomicroscope before starting session. 
 
In particular, we were interested in applying this technique for testing potential therapeutic 
compounds and drug carriers targeted for the treatment of retinitis pigmentosa (RP), one of the most 
common retinal degenerative disorders. Intravitreal injection is generally considered as the most 
effective way of delivering materials to the back of the eye, where the retina is located. In addition, 
we pointed out that zebrafish is an advantageous model, as fish eye is structurally similar to that of 
mammals (Giannaccini et al., 2014; Angueyra and Kindt, 2018). Our purpose was to evaluate the 
ability of intravitreally-injected drug candidates or differentiated mesenchymal stem cells to rescue 
retinal defects either in wild type zebrafish having chemical-induced retinal degeneration or in larvae 
obtained from specific RP transgenic lines.  
In parallel, we practiced intravenous microinjection, an excellent tool for the introduction of a variety 




this technique can be employed to test the efficiency and the potential side effects of gene therapy 
and drug delivery carriers (Cianciolo Cosentino, 2010; Duan et al., 2016). 
We have carried out several tests using different injection volumes to assess the best conditions for 
our needs. The injection volume was calculated by comparing it to the drop size based on the 
conversion table from Cold Spring Harbor Protocols (Tab. 1). 
 
Diameter of drop (μm) Radius of drop (μm) Volume (4/3[πr3]) (nl) 
150 75 1.77 
160 80 2.15 
170 85 2.58 
180 90 3.06 
200 100 4.20 
225 112.5 5.90 
 
Table 1 Conversion table for calculating microinjection volumes 
(http://cshprotocols.cshlp.org/content/2010/12/pdb.tab195537). 
 
Finally, we considered that a volume of about 2-3nl was the optimum for intravitreal injections, while 
the injection volume could be increased to 5nl for bloodstream injections (Cianciolo Cosentino et al., 
2010; Giannaccini et al., 2014). 
Zebrafish larvae were generally injected at 48 or 72hpf, when the development of retinal structure 
has already started and the circulatory system is complete. Moreover, the yolk sac was reduced, so 
positioning the larvae on the plate for the microinjection was easier. Successfully injected larvae were 
identified by observing the fluorescence in the vasculature or in the eye immediately after injection 







Figure 4. Representative examples of injected 48hpf-larvae with the Texas Red-conjugated dextran fluorescent dye in the 
bloodstream (A) and in the retinal epithelium (B). A’ and B’ are the equivalent pictures in bright field. 
 
After acquiring these skills, I moved to the Department of Molecular Life Sciences of the University 
of Zurich, where I should have used the described techniques for the following experiments of my 
thesis. The original plan involved the trans-differentiation of WJ-MSCs, derived from human 
umbilical cord discarded at birth, into photoreceptor-like and retinal pigment epithelium-like cells. 
Then, we would have evaluate the different ability of naïve and differentiated WJ-MSCs to rescue 
retinal defects either in wild type zebrafish larvae treated with N-methyl-N-nitrosourea to induce 
retinal degeneration or in larvae obtained from appropriate RP zebrafish lines, the latter housed at the 
host laboratory directed by Professor Stephan Neuhauss. In parallel, we would have evaluate the 
efficacy of intravitreally-injected morpholino oligonucleotides directed against selected aberrant 
mRNA splicing variants, for the correction of splicing defects in appropriate RP zebrafish larvae 
supplied by our colleagues in Zurich. 
The degree of vision correction in injected larvae would be assessed by measuring of optokinetic 
nystagmus and optomotor responses by using specific equipment at the host laboratory. Moreover, 
human gene expression should have been determined by quantitative PCR in cDNA samples derived 
from dissected eyes of injected fish. 
Unfortunately, the well-known Covid-19 outbreak emergency prevented my work in the laboratory 
abroad, forcing myself to return in Italy. To make matters worse, the “Azienda Ospedaliera Ospedali 
Riuniti Villa Sofia – Cervello” became a Covid Hospital, hindering our collaborators to provide naïve 





2. Microscopic observation of developing embryos 
We investigated the effects of the administered chemicals by checking embryonic development 
progression. For this purpose, embryos and larvae were observed daily under the stereomicroscope 
until 120hpf for assessing the survival rate of each treated group and normalizing it on the survival 
observed in control groups. In parallel, at each time-point, treated embryos and unperturbed controls 
were examined in detail to identify possible phenotypic alterations induced by the treatments. Somite 
formation, tail detachment and head development were evaluated at 24hpf, while the presence of 
heartbeat, oedema and pigmentation was evaluated at 48hpf. After hatching, the absorption of the 
yolk, the onset of skeletal deformities and variations in the body length were assessed.  











3. Apoptotic assay on 72hpf embryos 
Selective labelling of cells undergoing apoptosis was achieved by staining developing zebrafish with 
the vital fluorescent dye acridine orange (Tucker & Lardelli, 2007). Indeed, this dye permeates cells 
and emits a particularly strong green fluorescence when intercalated into fragmented DNA, which is 
a result of the apoptosis machinery at work (Negron et al., 2004; Eimon et al., 2010).  
Based on several attempts, we decided to perform this assay at 72hpf because at prior stages numerous 
foci of physiological morphogenetic and histogenetic apoptosis were detected, making it difficult to 
visualize apoptotic variations (Cole & Ross, 2001). Moreover, the apoptotic analysis in embryos at 
72hpf is convenient due to the reduced background noise derived from the auto-fluorescence of the 
yolk-sac, which is instead particularly prominent in the earlier stages.  
The Fig. 6 reports a summary of the observations carried out during preliminary tests. In particular, 
CdCl2-treated larvae display a broad staining pattern throughout the body, underling an enhanced 
ectopic apoptosis. By contrast, although the larva exposed to DMSO 2% has an abnormal 
morphology, it shows the physiological apoptotic focus occurring during the development, as shown 
in the control. 
 
                             
 
 
Figure 6. Acridine Orange staining allows to observe apoptosis in vivo in unperturbed control (A), and in larvae treated 









4. Behavioural analysis of swimming larvae 
At 120hpf, zebrafish larvae show mature swimming activity, which could provide important 
information for toxicological assays. Indeed, treatment of zebrafish larvae with potential neuroactive 
substances could change the response pattern of the larvae, which could then be used to determine 
whether a substance has a neuroactive property or not. Indeed, these locomotor activities depend on 
the integrity of brain function, nervous system development, and visual pathways (Ali et al., 2012).  
In light of this, we have included behavioural analysis in our protocol. We examined the locomotor 
activity and movement pattern of zebrafish larvae using the ViewPoint® ZebraLab, an automated 
live video tracking system (Fig. 7A). 
Parameters were adjusted as detailed in the Material and Methods section. While the experiment is 
running, the software detects the trajectories moved by the larvae and marks them by different colours 
based on the swim speed (Fig. 7B). Hence, the first output to evaluate at the end of the assay was the 
global path image, visually displaying how the larvae moved throughout the experiment (Fig. 7C). 
In parallel, larvae locomotor parameters are quantified by the software from the video recorded during 
the assay, and these raw data are essential to calculate the mean velocity, which indicates the average 








Figure 7. (A) Setting up ViewPoint® ZebraLab for the experiment. Once the plate with larvae is placed and the light 
switched on, the ViewPoint® ZebraBox chamber is closed and the experiment can be launched. (B) Frame of a video 
recorded while the experiment was running. The blue circles mark the wells containing larvae. Coloured lines highlight 
the trajectories moved by the larvae. (C) Global path moved by the 120hpf-larvae during the behavioural assay. The 
colours of the lines refer to different speed maintained, as described in the legend. (D) Variation of the mean velocity 















5. Molecular analysis: gene expression and epigenetic analysis 
Embryonic development is driven by changes in gene expression, whereas alteration in the epigenetic 
landscape and chromatin structure are major mechanisms that can simultaneously activate and repress 
the expression of multiple genes. Epigenetic marks, such as histone post-translational modifications 
and DNA methylation, alter nucleosome positioning, chromatin compaction, and transcription factor 
access to DNA. It is now clear that epigenetic mechanisms collaborate with the underlying genomic 
information to dictate whether a gene is transcriptionally active or silenced. 
In addition, epigenetic mechanisms may specifically mediate toxicity responses to certain chemicals 
(Baccarelli & Bollati, 2009; Mudbhary & Sadler, 2011). In this regard, we considered worthwhile to 
introduce in our protocol Reverse Transcription-PCR and Chromatin Immunoprecipitation (ChIP) to 
identify possible gene-specific transcriptional and epigenetic changes induced by the treatments of 
interest. While specific gene expression has been easily assessed starting from total RNA samples 
extracted from fish embryos using commercial kits, a challenging step of ChIP procedure was 
chromatin preparation. Indeed, ChIP is an experimental procedure in vivo that uses antibodies to 
determine whether a given protein binds specific tracts within a population of fragmented chromatin 
(Lindeman, 2009; Cavalieri & Spinelli, 2017; Yao et al., 2017; Cavalieri, 2020; Reina and Cavalieri, 
2020). 
We first tried to disaggregate whole fish embryos into single cells by forcing them through a syringe 
needle. However, we realized that this procedure was not completely successful and was 
unsatisfactory in terms of chromatin yield. Therefore, we decided to disaggregate embryos by gentle 
trypsinization after yolk removal with a specific buffer (Covassin et al., 2006; Link et al., 2006). We 
have tested that an incubation time of 20 minutes is enough to obtain a sufficient level of embryo 
dissociation in free intact cells or small aggregates (Fig. 8).  
 
  





Cells were then cross-linked with 1% formaldehyde and lysed, as described in Materials and Methods. 
This procedure typically yield 10μg of chromatin from 100 30hpf-embryos, which was enough for 
downstream experiments. 
Next, we have set up chromatin shearing by testing different sonication times to obtain a population 
of fragments with an average length of about 250 bp (Sadeh et al., 2016) (Fig. 9). This size is close 
to that of the single nucleosomal fraction, allowing using antibodies against post-translationally 
modified histones associated to the transcription status of the genes of interest. Finally, genomic 
sequences associated with the precipitated nucleoprotein complexes were identified by PCR, using 






Figure 9. Electrophoretic migration of reverted chromatin extracted from 30hpf-fixed embryos sheared at different 









Application of the experimental pipeline for toxicological analysis:  
developmental effects of exposure to Conditioned Media 
We extended the application of each step of our experimental protocol by testing the developmental 
effects of  a complex biological sample, in particular the conditioned medium derived from WJ-MSC 
isolated by umbilical cord and provided by our collaborators from “Azienda Ospedaliera Ospedali 
Riuniti Villa Sofia – Cervello” of Palermo.  
Bradford protein assay of CM revealed a concentration of 1500μg/mL (conventionally referred to as 
40X). This stock solution was diluted 1:40 (1X), 1:20 (2X) and 1:10 (4X) in E3 medium. In each 
assay, embryos from the same batches were used to establish three distinct control groups. Embryos 
of a first group were reared in the presence of equivalent amounts of DMEM. A second group of 
embryos was exposed to a “saline solution” having the same inorganic salts composition as DMEM. 
Finally, a third group of embryos was reared in E3 medium as a negative control.  
Thus, embryos were observed every 24 hours until the 120hpf stage, evaluating the survival rate and 
phenotypic changes, and data presented as the mean of quadruplicate experiments are summarised in 
Fig. 10. As expected, control embryos grown in E3 medium and in the presence of the saline solution 
were all alive and phenotypically normal at 120hpf. Surprisingly, a significantly reduced survival rate 
was detected during development of embryos exposed to DMEM. This effect was dose-dependent, 
causing the premature death of all embryos at 96hpf at the highest concentration of DMEM. By 
contrast, exposure to CM at all concentrations used did not affect the survival rate until 72hpf. 
However, at later time-points a dose -dependent decrease in the survival rate was detected in the CM-
treated embryos, leading to a maximum of 45% of dead larvae at 120hpf detected at the highest 
concentration.  
As predictable from the survival assessment, we observed the peculiar ability of DMEM to inflict 
major phenotypic deformities starting from early developmental stages (Fig. 11). Indeed, DMEM 
caused a range of alterations, including severe developmental delay, malabsorption of the yolk, 
crooked body and onset of pericardial and yolk-sac oedema. These abnormalities arouse in a dose-
dependent manner, whereas no normal embryos were detected starting from 24hpf following 
exposure to the highest concentration of DMEM (Fig. 10 and 11). By contrast, exposure to CM 
generally produced milder phenotypic alterations, whereas the developmental progression of embryos 




observed. In fact, about 25% of these embryos displayed either slight developmental delay or spinal 
curvature compared to control unperturbed embryos (Fig. 10 and 11). 
Altogether, these findings suggest that the molecular components contained in CM could somehow 




Figure 10. Survival rate and incidence of abnormal phenotypes of developing zebrafish exposed to the experimental 
concentrations of CM, DMEM, Saline Solution (SS) and E3 medium. Data are presented as the mean of quadruplicate 






Figure 11. Representative examples of the phenotypes observed with the indicated treatments. 
 
Next, by staining with acridine orange we investigated the apoptotic landscape in live control and 
treated 72hpf-larvae. Besides the above-mentioned control groups, in this assay we also included 
sibling larvae exposed to the sub-lethal concentration of 9μM CdCl2, which is a potent apoptotic 
inducer and represents a compelling positive control. CdCl2 was administered 24 hours before the 
assay started, in order to preserve larvae from drastic damages caused by prolonged exposure (Chan 
& Cheng, 2003; Monaco et al., 2017; Tucker & Lardelli, 2007; Chiarelli et al., 2019). As expected, 
control embryos reared in E3 medium and in saline solution displayed the normal developmental 
apoptotic spatial pattern, including a single greater focal point at the olfactory epithelial cells and a 
number of smaller apoptotic foci along the tail. Intriguingly, DMEM provoked a dose-dependent 
appearance of ectopic apoptosis in the pericardial region of the 90% of treated larvae (Fig. 12B) 
highlighting a linear correlation with the incidence of pericardial oedema in these embryos. In striking 
contrast, larvae exposed to all the concentrations of CM exhibited an essentially normal acridine 
orange staining, indicating that CM exposure did not induce variation in the physiological apoptotic 








Figure 12.  Apoptotic assay by acridine orange vital staining. (A) Sample images of treated and control 72hpf-larvae. 
Red arrows mark the ectopic apoptosis induced by DMEM exposure. (B) Details of the images at higher magnification. 






Alive 120hpf-larvae with minor o none visible morphological defects were selected from each 
experimental group for behavioural analysis. As reported in Fig. 13, we registered a maximum 
average reduction of 0.2 mm/sec in the locomotor activity of DMEM-treated embryos compared to 
the controls. However, based on preliminary tests and literature (Chen et al., 2011; Félix et al., 2018; 
Capriello et al., 2019) this is likely an irrelevant variation. Taken together, these data indicate that 




Figure 13. Histogram showing the mean velocity of the larvae during a 15 minutes assay. Data are reported as the mean 
10 120hpf-larvae per experiment. Raw data were processed with ViewPoint® FastData Manager (version 2.4.0.2510) 
and the charts drawn with Microsoft Excel 2016. Error bar = ± SD.  
 
Because of the lethal exert inflicted by treatment with DMEM at the highest concentration, we 
focused on the 2X experimental condition (including exposure to DMEM, CM and saline solution, 
as well as unperturbed controls) for downstream molecular characterization. In particular, we paid 
attention to some selected genes known to be involved in biological processes required for normal 
embryo development, such as apoptosis, neural development, inflammation and response to oxidative 








Biological process Name Abbreviation Bibliography 
APOPTOSIS 
B-cell lymphoma 2 
apoptosis regulator a 
bcl2a 
Lu et al., 2011 
Miccoli et al., 2015 
Tumoral protein 53 tp53 
Berghmans et al, 2005 
Espín et al., 2013 
Tumor Necrosis Factor 
Receptor Superfamily 
Member 1A 










Cortes et al., 2016 




Krysko et al., 2010 
Wang et al., 2011 
REFERENCE GENES 
18S rRNA 18S 
Tang et al., 2007 Beta Actin β-act 
Ribosomal protein L13 rpl13 
 







Exons and promoter sequences of each selected gene were identified by BLAST searches on the 
Ensembl (http://www.ensembl.org/Danio_rerio) public annotated sequence database. For the RT-
PCR assay, primer pairs targeted for Expression Sequence Tags (ESTs) were designed in the 
proximity of exon boundaries to avoid any non-specific amplification due to potential genomic DNA 
contamination. For the ChIP assay, primer pairs were picked on the basal promoter region of each 
gene, upstream of the Transcription Start Site (Fig. 14). The sequences of all primers were further 
checked using Primer Blast (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to ensure the absence 
of non-specific amplicons. 
 
 
Figure 14. Schematic drawing highlighting gene regions used for primer design. Primer FW= Primer Forward; Primer 
RW= Primer Reverse; TAAAT= TATA box; TSS = Transcription Start Site. 
 
For both molecular analysis, we used 30hpf-embryos because, at this developmental stage, the 
somitogenesis is complete, major vital organs are mostly formed (Kimmel et al., 1995), and the 
principal epigenetic patterns have been established (Balasubramanian et al., 2019).  
Fig. 15 shows the mRNA abundance of the target genes in samples derived from embryos exposed 
to 2X concentration of DMEM, CM and saline solution, as well as from control unperturbed embryos. 
Consistent with the behavioural data showing the absence of neurotoxic effects induced by CM and 
DMEM, bdnf mRNA abundance remained constant in all the experimental groups. Inflammatory 
response was probably not stimulated under the described experimental conditions, since no 
variations were found in the expression level of il8. 
Unexpectedly, a similar outcome was obtained for bcl2, tp53 and tnfrsf1a, suggesting that apoptotic 
pathways involving these genes were not affected. The apparent discordance between this result and 
evidence obtained from the apoptotic assay could be ascribed to the distinct developmental stages 
considered for these two analysis. It could be argued that, probably, DMEM exposure triggers ectopic 
apoptosis in a developmental time window between 30 and 72hpf.  
Intriguingly, the exposure to CM specifically increased the mRNA abundance of cat, suggesting a 





Figure 15. Semi-quantitative RT-PCR showing the expression level of the analysed genes transcripts in 30 hpf-embryos 
at the indicated treatments. 18S, β-act and rpl13 were used to control gene expression. 
 
These findings were further supported by ChIP analysis aimed to the investigation of epigenetic 
marks associated to transcriptional activation and maintenance of euchromatin, such as acetylation of 
H4 (H4ac) and trimethylation of H3 lysine 9 (H3K4me3), and the negative epigenetic mark 
trimethylation of H3 lysine 9 (H3K9me3), associated with heterochromatin.  
In particular, ChIP assays highlighted unchanged accumulation of the mentioned epigenetic marks at 
the promoter of bcl2, tp53 and tnfrsf1a in chromatin samples derived from all the experimental 
groups, confirming the unaffected transcriptional outcome for these genes (Fig. 16). Most 
importantly, these experiments also revealed a concordant and specific increase in the occupancy of 
both H3K4me3 and H4ac modified nucleosomes at the promoter of the cat gene in CM 2X-treated 
embryos. In strict accordance, the negative epigenetic mark H3K9me3 was almost depleted in 
nucleosome occupying the same promoter region. Altogether, these findings well justify the increased 


























To date, the zebrafish model is the main available high-throughput vertebrate assessment system with 
high translational power on humans. Moreover, the transparency of the embryos and their rapid 
development are uniquely suited for real-time in vivo studies of toxicity (Garcia et al., 2016; Cassar 
et al., 2020). For these reasons, the design and implementation of screening formats on zebrafish, 
targeting a wide range of pathways and endpoints (e.g. teratogenicity, cardiotoxicity, neurotoxicity 
etc.), has grown steadily in recent years. A continuously increasing trend in scientific publications in 
the field of zebrafish toxicity is also observed, with latest yearly reports being four times those from 
ten years ago (Cassar et al, 2020).  
In this scenario, we took advantage of the innovative equipment available in the Zebrafish Laboratory 
recently established at the University of Palermo to devise a multi-parametric assay platform for the 
in vivo toxicological analysis of potential therapeutic compounds and new drug candidates. This 
experimental workflow combines different approaches to achieve rapid and simultaneous analysis of 
morphological, apoptotic, behavioural and molecular changes inflicted by multiple compounds at 
different concentrations during zebrafish embryogenesis. The robustness of this pipeline has been 
validated using distinct water-soluble chemicals (including cadmium chloride, dimethylsulfoxide, 
ethanol and tricaine) known to induce developmental aberrations in zebrafish at specific 
concentration ranges (Chen et al., 2011; Monaco et al., 2017; Ramlan et al., 2017; Félix et al., 2018; 
Capriello et al., 2019). 
This successful validation step encouraged the application of our assay to evaluate comprehensively 
the developmental effects of CM derived from WJ-MSCs. The importance of such a complex 
biological mixture deals with recent characterization on mammals, highlighting that the use of CM 
offers a therapeutic alternative to direct stem cells transplantation as it provides broadly similar effects 
(Vizoso et al., 2017; Chudickova et al., 2019; Hsieh et al., 2013; Stefańska et al., 2020).  
Comparative analysis of zebrafish embryos exposed to CM and DMEM (which is the non-
conditioned counterpart medium), comprehensively suggests favourable effects of CM during 
development. These beneficial effects are fully justified considering that the MSC-derived CM 
generally contains trophic factors, chemokines, anti-inflammatory cytokines, anti-apoptotic factors, 
etc. (Kupcova, 2013). Indeed, exposure to CM prevented the onset of ectopic apoptotic spots observed 
following treatment with the standard culture medium, and preserved both the expression of the 




similar data from the available literature. For example, exposure of adult zebrafish model of traumatic 
brain injury to CM derived from human umbilical cord perivascular cells elicited anti-apoptotic and 
neuroprotective effects, accelerating the recovery of the normal swimming activity (Liu et al., 2020).   
Another interesting finding derived from our investigations pertains the protective effect of CM 
against oxidative stress through the establishment of a permissive epigenetic environment on the 
catalase gene promoter, which allows specific and significant upregulation of catalase gene 
expression in CM-treated embryos. Accordingly, published evidence highlights that the effect of CM 
against oxidative stress in various experimental systems indeed occurs through the increased mRNA 
expression level of catalase and superoxide dismutase, which hydrolyze reactive oxygen species, 
thus attenuating cell damage caused by free radicals (Wang et al., 2011; Sohn et a., 2018; Li et al., 
2019; Liu et al., 2020). 
In sum, our findings provide a promising outlook for the therapeutic role of WJ-MSCs and encourage 
the employment of CM derived from WJ-MSCs for clinical use. On the other hand, several issues 
needs to be pursued. For example, the identification of the bioactive factors contained in the CM used 
in our experiments not only should greatly facilitate future understanding of the mechanisms 
influenced during embryogenesis, but it may also help explain the sporadic aberrations observed in 
the CM-treated embryos. Future work must also concern an extended gene expression analysis on 
further key markers, to better describe the beneficial molecular landscape determined by CM 
treatment. Finally, it would also be interesting to evaluate the ability of CM to rescue developmental 
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